Intuitive Surgical, Inc. $ISRG Shares Sold by Geneva Capital Management LLC

Geneva Capital Management LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.2% in the second quarter, HoldingsChannel reports. The firm owned 4,113 shares of the medical equipment provider’s stock after selling 138 shares during the period. Geneva Capital Management LLC’s holdings in Intuitive Surgical were worth $2,235,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of ISRG. Brighton Jones LLC grew its holdings in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the period. Golden State Wealth Management LLC grew its holdings in shares of Intuitive Surgical by 13.7% in the first quarter. Golden State Wealth Management LLC now owns 1,757 shares of the medical equipment provider’s stock valued at $870,000 after purchasing an additional 212 shares during the period. Private Trust Co. NA grew its holdings in shares of Intuitive Surgical by 40.3% in the first quarter. Private Trust Co. NA now owns 1,423 shares of the medical equipment provider’s stock valued at $705,000 after purchasing an additional 409 shares during the period. D.A. Davidson & CO. grew its holdings in shares of Intuitive Surgical by 2.5% in the first quarter. D.A. Davidson & CO. now owns 13,524 shares of the medical equipment provider’s stock valued at $6,698,000 after purchasing an additional 326 shares during the period. Finally, Silver Oak Securities Incorporated grew its holdings in shares of Intuitive Surgical by 17.5% in the first quarter. Silver Oak Securities Incorporated now owns 2,097 shares of the medical equipment provider’s stock valued at $1,031,000 after purchasing an additional 313 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $534.28 on Friday. The business has a 50-day moving average of $464.32 and a 200 day moving average of $498.61. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock has a market capitalization of $191.53 billion, a price-to-earnings ratio of 70.67, a price-to-earnings-growth ratio of 4.94 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same period last year, the business posted $1.84 EPS. Intuitive Surgical’s revenue for the quarter was up 22.9% on a year-over-year basis. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on ISRG shares. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Truist Financial set a $620.00 target price on shares of Intuitive Surgical and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Royal Bank Of Canada set a $625.00 price target on shares of Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Finally, Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $608.92.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 7,562 shares of the firm’s stock in a transaction dated Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at $193,595.79. This trade represents a 95.54% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. The trade was a 23.83% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 96,011 shares of company stock worth $50,309,042 over the last ninety days. Company insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.